- Home
- UTMD vs GNLX Comparison
UTMD vs GNLX Comparison
Compare UTMD & GNLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UTMD
- GNLX
- Stock Information
- Founded
- UTMD 1978
- GNLX 2001
- Country
- UTMD United States
- GNLX United States
- Employees
- UTMD N/A
- GNLX N/A
- Industry
- UTMD Medical/Dental Instruments
- GNLX Biotechnology: Pharmaceutical Preparations
- Sector
- UTMD Health Care
- GNLX Health Care
- Exchange
- UTMD Nasdaq
- GNLX Nasdaq
- Market Cap
- UTMD 171.3M
- GNLX 184.4M
- IPO Year
- UTMD N/A
- GNLX 2023
- Fundamental
- Price
- UTMD $53.60
- GNLX $2.96
- Analyst Decision
- UTMD
- GNLX Strong Buy
- Analyst Count
- UTMD 0
- GNLX 4
- Target Price
- UTMD N/A
- GNLX $17.75
- AVG Volume (30 Days)
- UTMD 15.6K
- GNLX 138.3K
- Earning Date
- UTMD 04-29-2025
- GNLX 05-06-2025
- Dividend Yield
- UTMD 2.27%
- GNLX N/A
- EPS Growth
- UTMD N/A
- GNLX N/A
- EPS
- UTMD 3.78
- GNLX N/A
- Revenue
- UTMD $39,273,000.00
- GNLX N/A
- Revenue This Year
- UTMD N/A
- GNLX N/A
- Revenue Next Year
- UTMD N/A
- GNLX N/A
- P/E Ratio
- UTMD $14.24
- GNLX N/A
- Revenue Growth
- UTMD N/A
- GNLX N/A
- 52 Week Low
- UTMD $51.26
- GNLX $1.60
- 52 Week High
- UTMD $77.33
- GNLX $5.89
- Technical
- Relative Strength Index (RSI)
- UTMD 48.81
- GNLX 54.28
- Support Level
- UTMD $51.80
- GNLX $2.26
- Resistance Level
- UTMD $54.78
- GNLX $3.06
- Average True Range (ATR)
- UTMD 1.22
- GNLX 0.31
- MACD
- UTMD 0.35
- GNLX 0.04
- Stochastic Oscillator
- UTMD 66.48
- GNLX 78.42
About UTMD Utah Medical Products Inc.
Utah Medical Products Inc is involved in the business of developing, manufacturing, and distributing medical devices that are mainly proprietary, disposable, and for hospital use. The firm produces its products for Blood pressure monitoring, Blood collection, Electrosurgery, Gynecology, Neonatal critical care, perinatology, and Urology. The company's product portfolio includes Electrosurgical pens, Tenacula, Endoscopic bulb irrigators, and Blood bag spikes. Its products are used mainly in critical care areas, labor and delivery departments of hospitals, and outpatient clinics and physicians' offices.
About GNLX Genelux Corporation
Genelux Corp is a clinical-stage biopharmaceutical company. The company focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive or difficult-to-treat solid tumor types. Its pipeline products include Olvi-Vec (olvimulogene nanivacirepvec) and others.